Unlike earlier compounds that target a single pathway, Retatrutide is designed to activate three different receptors involved in energy balance and metabolism: GLP-1, GIP and glucagon receptors
Alongside medication, your plan offers ongoing behavioral and nutritional support, including guidance on diet, exercise, and lifestyle changes, supported by motivational coaching to encourage lasting habits
Several developments may change how resets are approached in the coming years
DZIC is supported by a Department of Medicine, University of Toronto Merit Award and receives support from the CIHR, Diabetes Canada and the Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research
GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes
While GLP-1 drugs can be highly effective for weight loss and diabetes management, they work best as part of comprehensive treatment plans that include dietary changes and physical activity